# The company has signed an agreement to acquire select product assets from Sanofi.

*biotech · news · 2026-04-24 · Free Press Journal*

## Key points

- Gujarat Themis Biosyn is acquiring 13 Sanofi brands in anti-infectives and tuberculosis for €158 million.
- The deal excludes manufacturing facilities or employees, streamlining integration and reducing complexity.
- The acquired brands generated €62 million in FY2025 revenue, with 70% from retail channels.
- This acquisition gives Gujarat Themis immediate presence in 55 countries, mostly in Europe, the Middle East, and Africa.
- The company plans to reactivate dormant marketing authorizations and expand in high tuberculosis burden markets.

**Companies:** Gujarat Themis Biosyn
**Countries:** India, France

[Read the full story on Free Press Journal](https://www.freepressjournal.in/business/gujarat-themis-biosyn-acquires-sanofi-portfolio-in-1738-crore-deal-to-expand-global-reach)

---

Canonical: https://newsio.io/n/5039bdab-1635-44ed-ba80-dba5a764f831/the-company-has-signed-an-agreement-to-acquire-select-product-assets-from-sanofi
Summarized by Newsio from Free Press Journal. https://newsio.io/how-it-works